Octagon Capital Advisors LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Octagon Capital Advisors LP disclosed 41 US equity positions worth $624.7m in its Q3 2024 13F filing. The largest position was APLSUSD at 13.9% of the reported book, followed by VRNA and GPCR.
What did Octagon Capital Advisors LP own in Q3 2024? Top 41 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | APLSUSD APELLIS PHARMACEUTICALS INC | 13.9% | $86.7m | 3,006,980 | – | ||
| 2 | VRNA VERONA PHARMA PLC | 8.5% | $52.8m | 1,835,200 | – | ||
| 3 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 8.4% | $52.6m | 1,198,000 | – | |
| 4 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 7.7% | $47.8m | 1,746,667 | – | |
| 5 | AVBP ARRIVENT BIOPHARMA INC | 7.4% | $46.4m | 1,976,387 | – | ||
| 6 | CNTA CENTESSA PHARMACEUTICALS PLC | 5.2% | $32.2m | 2,012,052 | – | ||
| 7 | INSM INSMED INC | Healthcare | 5.1% | $31.9m | 436,820 | – | |
| 8 | NUVB NUVATION BIO INC | Healthcare | 4.5% | $27.9m | 12,171,513 | – | |
| 9 | CRBP CORBUS PHARMACEUTICALS HLDGS | Healthcare | 3.7% | $23.0m | 1,115,000 | – | |
| 10 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 3.4% | $21.1m | 2,425,000 | – | |
| 11 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 3.2% | $19.8m | 870,000 | – | |
| 12 | CATX PERSPECTIVE THERAPEUTICS INC | 3.0% | $19.0m | 1,422,224 | – | ||
| 13 | BRD1EUR MIND MEDICINE MINDMED INC | 2.7% | $17.2m | 3,018,000 | – | ||
| 14 | COGT COGENT BIOSCIENCES INC | Healthcare | 2.3% | $14.1m | 1,305,000 | – | |
| 15 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 2.2% | $14.1m | 552,000 | – | |
| 16 | PHVS PHARVARIS N V | 1.8% | $11.5m | 620,470 | – | ||
| 17 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.5% | $9.4m | 262,726 | – | |
| 18 | TSHA TAYSHA GENE THERAPIES INC | Healthcare | 1.5% | $9.2m | 4,572,222 | – | |
| 19 | GOSS GOSSAMER BIO INC | Healthcare | 1.5% | $9.1m | 9,187,883 | – | |
| 20 | ALLOVIR INC | 1.4% | $9.1m | 11,202,000 | – | ||
| 21 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 1.4% | $8.7m | 1,093,503 | – | |
| 22 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 1.2% | $7.5m | 130,000 | – | |
| 23 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.2% | $7.3m | 600,000 | – | |
| 24 | RGLS REGULUS THERAPEUTICS INC | 1.1% | $6.7m | 4,263,701 | – | ||
| 25 | VTYXUSD VENTYX BIOSCIENCES INC | 0.8% | $5.2m | 2,391,114 | – | ||
| 26 | TNYA TENAYA THERAPEUTICS INC | 0.8% | $5.0m | 2,576,200 | – | ||
| 27 | HELP CYBIN INC | 0.7% | $4.4m | 489,596 | – | ||
| 28 | RENEO PHARMACEUTICALS INC | 0.6% | $3.8m | 2,250,000 | – | ||
| 29 | UNCY UNICYCIVE THERAPEUTICS INC | 0.6% | $3.5m | 8,559,000 | – | ||
| 30 | PEPG PEPGEN INC | Healthcare | 0.5% | $3.2m | 376,117 | – | |
| 31 | HELIX ACQUISITION CORP II | 0.4% | $2.6m | 250,000 | – | ||
| 32 | BDTX BLACK DIAMOND THERAPEUTICS I | 0.4% | $2.6m | 594,000 | – | ||
| 33 | ANNX ANNEXON INC | Healthcare | 0.4% | $2.4m | 400,000 | – | |
| 34 | MERSANA THERAPEUTICS INC | 0.3% | $1.9m | 992,000 | – | ||
| 35 | IPSC CENTURY THERAPEUTICS INC | Healthcare | 0.2% | $1.1m | 666,825 | – | |
| 36 | AEROVATE THERAPEUTICS INC | 0.2% | $972.8k | 465,440 | – | ||
| 37 | NUVATION BIO INC | 0.1% | $715.2k | 312,336 | – | ||
| 38 | AUTL AUTOLUS THERAPEUTICS PLC | Healthcare | 0.1% | $638.9k | 176,000 | – | |
| 39 | NGNE NEUROGENE INC | 0.1% | $629.4k | 15,000 | – | ||
| 40 | RAPT THERAPEUTICS INC | 0.1% | $586.9k | 292,000 | – | ||
| 41 | NKTX NKARTA INC | Healthcare | 0.1% | $542.4k | 120,000 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.